PMGC HOLDINGS INC. Share-based Compensation Arrangement by Share-based Payment Award, Options, Forfeitures in Period
PMGC HOLDINGS INC. (ELAB) reported Share-based Compensation Arrangement by Share-based Payment Award, Options, Forfeitures in Period of 407 shares for the 12-month period ending 2024-12-31, per its 10-K filed 2025-03-28.
Financial Statements › Shareholders' Equity › Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Grants in Period, Net of Forfeitures
us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresInPeriod · last filed 2025-03-28
- PMGC HOLDINGS INC. share-based compensation arrangement by share-based payment award, options, forfeitures in period for the quarter ending 2024-12-31 was -394.58K shares.
- PMGC HOLDINGS INC. share-based compensation arrangement by share-based payment award, options, forfeitures in period for the quarter ending 2024-09-30 was 128.38K shares.
- PMGC HOLDINGS INC. share-based compensation arrangement by share-based payment award, options, forfeitures in period for fiscal 2024 was 407.00 shares, a 3970.00% increase from fiscal 2023.
- PMGC HOLDINGS INC. share-based compensation arrangement by share-based payment award, options, forfeitures in period for fiscal 2023 was 10.00 shares.
| Period end | Share-based Compensation Arrangement by Share-based Payment Award, Options, Forfeitures in Period 0 month | Share-based Compensation Arrangement by Share-based Payment Award, Options, Forfeitures in Period | Share-based Compensation Arrangement by Share-based Payment Award, Options, Forfeitures in Period 3 month | Share-based Compensation Arrangement by Share-based Payment Award, Options, Forfeitures in Period 6 month | Share-based Compensation Arrangement by Share-based Payment Award, Options, Forfeitures in Period 9 month | Share-based Compensation Arrangement by Share-based Payment Award, Options, Forfeitures in Period 12 month | Share-based Compensation Arrangement by Share-based Payment Award, Options, Forfeitures in Period 12 month as first filed |
|---|---|---|---|---|---|---|---|
| 2024-12-31 | -394.58K shares derived: 10-K 12 month − 10-Q 9 month · filed 2025-03-28 | -266.20K shares derived: sum of 2 quarters · filed 2025-03-28 | 407.00 shares 10-K · filed 2025-03-28 | ||||
| 2024-09-30 | 128.38K shares derived: 10-Q 9 month − 10-Q 6 month · filed 2024-11-14 | 394.99K shares 10-Q · filed 2024-11-14 | |||||
| 2024-06-30 | 266.61K shares 10-Q · filed 2024-08-14 | ||||||
| 2023-12-31 | 10.00 shares 10-K · filed 2025-03-28 | 14.58K shares 10-Q · filed 2024-08-14 | |||||
| 2023-06-30 | 80.00K shares 10-K · filed 2024-03-29 | 80.00K shares 10-Q · filed 2023-12-11 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| FILANA THERAPEUTICS, INC. (FLNA) | United States | $0.038B | -1.05 |
| Actinium Pharmaceuticals, Inc. (ATNM) | United States | $0.038B | 2.73 |
| Celularity Inc (CELU) | United States | $0.038B | -0.34 |
| BriaCell Therapeutics Corp. (BCTX) | $0.037B | ||
| CervoMed Inc. (CRVO) | United States | $0.038B | -1.39 |
| Seres Therapeutics, Inc. (MCRB) | United States | $0.036B | -3.45 |
| Edesa Biotech, Inc. (EDSA) | Canada | $0.039B | |
| MIRA PHARMACEUTICALS, INC. (MIRA) | United States | $0.036B | -4.30 |
| Karyopharm Therapeutics Inc. (KPTI) | United States | $0.039B | -0.98 |
| ROCKWELL MEDICAL, INC. (RMTI) | United States | $0.035B |